Menu
Washingtoner
  • Home
  • Financial
  • Technology
  • Non-profit
  • Construction
  • Services
  • Home
  • Business
  • Education
Washingtoner

Strong Revenue Gains, Accelerating Growth, Strategic Hospital Expansion & Uplisting Advancements: Cardiff Lexington Corporation (Stock Symbol: CDIX)
Washingtoner/10312144

Trending...
  • Amicly Launches as a Safety-First Social App Designed to Help People Build Real, Meaningful Friendships
  • Primeindexer Google indexing platform launched by SEO Danmark APS
  • Spokane: Water Wise Wednesday Workshops Begin March 4
Cardiff Lexington Corp. Stock Symbol: CDIX $CDIX Cardiff Lexington Corp. Stock Symbol: CDIX $CDIX Corporate Ads
First Procedures Performed in Florida by $CDIX Demonstrate Commitment to Best-in-Class Healthcare for Underserved Traumatic Injury Populations

LAS VEGAS - Washingtoner -- Cardiff Lexington Corporation (Stock Symbol: CDIX), a targeted healthcare holding company specializing in orthopedic, spine, and pain-management clinic acquisitions, continues its aggressive growth trajectory in 2025. The company is demonstrating both operational execution and financial momentum, underscored by triple-digit quarterly growth, expanding clinical capabilities, and significant strategic progress toward uplisting.

Record Financial Growth in 2025

CDIX reported exceptional third-quarter 2025 results, showing dramatic expansion across all major financial metrics:
  • Q3 2025 Revenue: Up 125.6% to $3.1 million
  • Q3 2025 Gross Profit: Up 437.8% to $1.9 million
  • Q3 2025 Income from Continuing Operations: Up 209.9% to $643,000

Year-to-date performance further demonstrates consistent execution:
  • YTD Revenue: Up 70.2% to $8.8 million, compared to $5.1 million in the first nine months of 2024
  • YTD Gross Profit: Up 126.2% to $5.4 million
  • YTD Operating Income: Increased to $1.8 million, compared with a 2024 loss
  • Total Assets: Increased 15.4% to $27.6 million

These results reinforce the strength of the company's scalable healthcare platform and its focused acquisition strategy.

A Healthcare Platform Built for Growth

All current CDIX revenues are generated through its subsidiary Nova Ortho and Spine, LLC, which operates a growing network of orthopedic, spine, and pain-management centers across Florida and Georgia. These centers deliver:
  • Comprehensive diagnostic and surgical services
  • Interventional pain management
  • Primary care evaluations
  • Specialty orthopedic and spinal consultations

CDIX's model targets middle-market niche clinics that provide high-demand medical services—an area of the healthcare sector known for strong margins and consolidation opportunities.

More on Washingtoner
  • Tacoma: Registration Now Open for Grit City Connect Networking Event
  • HiLine Homes Celebrates Grand Opening of Marysville Model Home with Ribbon-Cutting Ceremony
  • Spokane: City Council Bans Use of Private Property for Detention Facilities
  • Spring Surge in 55+ Communities: What Buyers and Sellers Need to Know in 2026
  • Spokane: City Council Adopts "Immigration Enforcement Free Zones" Ordinance

First Procedures Completed at Doctor's Memorial Hospital: Expanding Access to Rural Florida

On December 11th, CDIX announced a major operational milestone: Nova Ortho and Spine successfully performed its first procedures at Doctor's Memorial Hospital in Perry, Florida.

This expansion represents more than growth—it signals a direct commitment to bringing high-quality orthopedic and pain-management care to severely underserved rural patient populations.

CEO Alex Cunningham commented:

"Our presence at Doctor's Memorial Hospital reinforces our commitment to providing best-in-class, accessible healthcare to the underserved and more rural areas around Florida. We quickly mobilized to bring our leading pain management and orthopedic and spinal surgical procedures to Taylor County, and we look forward to expanding into additional regions where we can further enhance healthcare standards and practices."

This hospital integration is expected to support continued revenue growth while positioning CDIX as a regional leader in bridging healthcare gaps across the Southeast.

Strengthening Corporate Governance and Uplisting Readiness

A key part of CDIX's growth strategy is its planned uplist to a senior exchange. Advancing that effort, the company recently entered into an advisory agreement with Greentree Financial Group, Inc., a firm specializing in corporate governance, financial reporting, and public-market compliance.

Greentree will guide CDIX on:
  • Audit processes
  • S-1 filing preparation
  • SEC and exchange responses
  • Governance enhancements
  • Coordination with attorneys, CPAs, and transfer agents

This engagement underscores the company's commitment to financial discipline, transparency, and readiness to scale as a next-generation healthcare platform.

More on Washingtoner
  • Spokane City Council Approves Prohibition of Kraton Sales
  • Jason Caras Launches The Caras Institute Following Successful Exit from IT Authorities
  • Tacoma: Mayor Anders Ibsen to Deliver First State of the City Address on March 4
  • Serina Damesworth Hired as Century Fasteners Corp. – Director of Quality
  • City of Tacoma to Host Free Virtual 'Capability Statements 101' Workshop on March 11

A Compelling Growth Story for Healthcare Investors

Cardiff Lexington has positioned itself at the intersection of rapidly growing healthcare demand, operational scalability, and underserved-market expansion. With a proven clinic-acquisition model and a successful track record of integrating and growing specialty medical centers, CDIX is strengthening its foundation for long-term value creation.

Investors watching the small-cap healthcare space may find CDIX's trajectory notable:
  • Strong balance-sheet expansion
  • Triple-digit improvements in profitability
  • Strategic partnerships supporting an uplisting path
  • Continued expansion into high-need medical markets

As CDIX accelerates its footprint and advances its strategy, the company appears well-positioned for continued growth in 2026 and beyond.

For More Information

Cardiff Lexington Corporation (Stock Symbol: CDIX)

CEO: Alex Cunningham
Email: investorsrelations@cardifflexington.com
Phone: (800) 628-2100 ext. 705
Website: https://cardifflexington.com/

DISCLAIMER:
https://corporateads.com/disclaimer/
Disclosure listed on the CorporateAds website

Contact
CorporateAds
***@gmail.com


Source: CorporateAds
Filed Under: Financial

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Progressive Dental & The Closing Institute Partner with Zest Dental Solutions to Elevate Full-Arch Growth and Patient Outcomes
  • CCHR: While Damaging Antipsychotics Win Approval, Proven Non-Drug Alternatives Remain Ignored
  • Arcuri Group Announces Long‑Term Partnership with WakeMed Health & Hospitals to Deliver Situational Awareness and De‑escalation Training
  • At 25, She Became One of the Youngest AAPI Female Founders to Win One of the World's Most Prestigious Design Awards for a Lamp That Makes You Smile
  • Juego Studios Extends Full-Cycle Game Development & Outsourcing Capabilities to the UAE Market
  • Spokane: Funding Available for Tourism and Cultural Investment Grant
  • VENUS Goes Live on CATEX Exchange As UK Financial Ltd Activates The Premier Division Of The Maya Meme's League
  • Our Purpose ​ —To give "We The People" their voice back—
  • Atlanta Tech Founder Seeks Clarity on Intellectual Property and Innovation Policy
  • Spokane: SPD Releases the Names of the Officers Involved in the OIS on Carlisle
  • Spokane: Water Wise Wednesday Workshops Begin March 4
  • Purple Heart Recipient Honored by Hall of Fame Son In Viral Tribute Sparking National Conversation on Service Fatherhood, Healing and Legacy
  • Firefighters Contain Two Separate West Spokane Fires Thursday Afternoon
  • Tacoma: WIAA/Gesa Credit Union Basketball Tournament
  • Amicly Launches as a Safety-First Social App Designed to Help People Build Real, Meaningful Friendships
  • Primeindexer Google indexing platform launched by SEO Danmark APS
  • Kaltra Introduces New Downward-Spraying Distribution Technology to Boost Microchannel Evaporator Performance
  • Talentica Announces Winners of Multi-Agent Hackathon 2026
  • Tacoma: Applicants Sought for the Public Utility Board
  • Special Alert: Undervalued Opportunity: IQSTEL (N A S D A Q: IQST) Positioned for Explosive Multi-Year Growth
_catLbl0 _catLbl1

Popular on Washingtoner

  • OneVizion Announces Next Phase of Growth as Brad Kitchens Joins Board of Directors - 126
  • Still Using Ice? FrostSkin Reinvents Hydration
  • Spokane City Council Members Introduce "Immigration Enforcement Free Zones"
  • Male In Custody After North Spokane Drive By Shooting
  • City of Tacoma Offers In-Person Workshop for Local Businesses on the Revolving Loan Fund Process
  • Investigation Into North Spokane Shooting That Left Two Dead Continues
  • Spokane: 2026 Safe Streets For All (Traffic Calming) Updates
  • City Council Confirms Appointment of Patti Jackson as Tacoma’s Police Chief
  • Cold. Clean. Anywhere. Meet FrostSkin
  • Nashville International Chopin Piano Competition Launches First Amateur Edition

Similar on Washingtoner

  • Progressive Dental & The Closing Institute Partner with Zest Dental Solutions to Elevate Full-Arch Growth and Patient Outcomes
  • Jason Caras Launches The Caras Institute Following Successful Exit from IT Authorities
  • National Expansion Ignited Across Amazon $AMZN, Chewy $CHWY & Walmart $WMT: NDT Pharmaceuticals, Inc. (Stock Symbol: NDTP) $NDTP
  • Tarrytown Expocare Pharmacy Announces Strategic Leadership Appointments to Accelerate Growth and Innovation
  • New Environmental Thriller "The Star Thrower" Reimagines a Classic Lesson in Individual Impact
  • Summit Appoints Javier Cabeza as Data, AI, and Analytics Practice Lead
  • Cancun Airport Transportation Expands Fleet Ahead of Record Passenger Growth at Cancun International Airport
  • NaturismRE Launches the NRE Health Institute to Advance Evidence-Informed Public Health Research
  • Progressive Dental & The Closing Institute Partner with Zest Dental Solutions to Elevate Full-Arch Growth and Patient Outcomes
  • CCHR: While Damaging Antipsychotics Win Approval, Proven Non-Drug Alternatives Remain Ignored
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute